HAA-09
HAA-09 is an orally active and potent anti-influenza agent, targeting the influenza PB2_cap binding domain. HAA-09 displays potent anti-influenza A virus activity, with an EC50 of 0.03 μM. HAA-09 shows polymerase inhibition, with an IC50 of 0.06±0.004 μM. HAA-09 blocks virus replication without causing obvious cytotoxicity.
For research use only. We do not sell to patients.
- CAS No.: 1422051-33-9
- Formula: C17H18F2N6O2
- Molecular Weight:376.36
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
IC50: 0.06±0.004 μM (polymerase); EC50: 0.03 μM (influenza A virus)[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | CC50 |
>100 μM
Compound: HAA-09
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 96 hrs by CCK-8 method
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 96 hrs by CCK-8 method
|
[PMID: 36773549] |
In Vitro
HAA-09 exhibits a stronger antiviral activity against oseltamivir-sensitive A/WSN/33 and oseltamivir-resistant H275Y variant, superior to oseltamivir[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
HAA-09 (0-25 mg/kg; Orally, BID) exhibits anti-influenza virus efficacy in mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Balb/C mice[1]
-
Dosage:40 mg/kg
-
Administration:Orally, QD (once daily) for consecutive 3 days
-
Result:Demonstrated a favorable safety profile when orally administrated in healthy mice.
-
Animal Model:Female BALB/c mice (6–8 weeks)[1]
-
Dosage:12.5, 25 mg/kg
-
Administration:Orally, BID (twice daily) starting 48 h post infection for 9 days
-
Result:Demonstrated in vivo therapeutic efficacy (85.7% survival observed at the day 15 post infection).
Chemical Information
-
CAS No. 1422051-33-9
-
Molecular Weight 376.36
-
Formula C17H18F2N6O2
-
SMILES
CC(C)(N(NC1=C(C=NC(C2=CNC3=C2C=C(C=N3)F)=N1)F)CC(O)=O)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)